Fields »
ABOUT
HELP
BLOG

274 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 6 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
CR2Complement component (3d/Epstein Barr virus) receptor 2
Breast cancer: 6.90e-4
Group enriched22appendix:70.8
lymph node:207.6
spleen:101.3
tonsil:159.4
FAM129CFamily with sequence similarity 129, member C
Group enriched15appendix:14.5
bone marrow:11.3
lymph node:28.5
spleen:37.6
tonsil:9.7
MS4A1Membrane-spanning 4-domains, subfamily A, member 1
Breast cancer: 4.34e-5
Group enriched15appendix:249.3
lymph node:780.6
spleen:476.2
tonsil:821.5
EN1Engrailed homeobox 1
Nucleus
Nucleoli		Group enriched13adipose tissue:1.3
breast:1.0
lymph node:1.9
skeletal muscle:4.7
skin:2.2
FCRL3Fc receptor-like 3
Group enriched12appendix:18.8
lymph node:56.6
spleen:37.3
tonsil:33.6
AICDAActivation-induced cytidine deaminase
Group enriched11appendix:5.1
lymph node:18.9
tonsil:11.5
CD19CD19 molecule
Group enriched11appendix:38.8
lymph node:85.0
spleen:48.2
tonsil:70.8
BLKBLK proto-oncogene, Src family tyrosine kinase
Group enriched10appendix:22.9
lymph node:61.9
spleen:41.3
tonsil:54.0
CLEC17AC-type lectin domain family 17, member A
Group enriched10appendix:17.3
lymph node:30.8
spleen:19.8
tonsil:29.7
FCRLAFc receptor-like A
Group enriched10appendix:32.5
lymph node:81.6
spleen:57.4
tonsil:90.1
P2RX5Purinergic receptor P2X, ligand gated ion channel, 5
CytosolGroup enriched10appendix:42.6
lymph node:90.9
spleen:75.5
tonsil:48.4
SERPINA9Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
Group enriched10appendix:17.7
lymph node:51.0
tonsil:68.9
TNFRSF13CTumor necrosis factor receptor superfamily, member 13C
NucleusCervical cancer: 4.44e-7
Group enriched10appendix:23.8
lymph node:46.7
spleen:44.4
tonsil:51.9
CHIT1Chitinase 1 (chitotriosidase)
Cervical cancer: 2.02e-4
Group enriched9bone marrow:31.3
breast:10.7
cervix, uterine:13.4
lung:53.2
lymph node:21.5
MEF2BMyocyte enhancer factor 2B
Group enriched9appendix:18.2
lymph node:46.3
tonsil:28.2
CD72CD72 molecule
Nucleus
Mitochondria		Renal cancer: 2.49e-8
Group enriched8appendix:26.2
lymph node:72.0
spleen:65.9
tonsil:44.3
FCRL2Fc receptor-like 2
Group enriched8appendix:16.9
lymph node:28.7
spleen:26.3
tonsil:24.6
LTBLymphotoxin beta (TNF superfamily, member 3)
CentrosomeRenal cancer: 3.31e-7
Endometrial cancer: 2.36e-6
Head and neck cancer: 1.74e-4
Group enriched8appendix:19.4
lymph node:22.5
spleen:26.4
tonsil:10.6
BTLAB and T lymphocyte associated
Group enriched7appendix:14.7
lymph node:29.6
spleen:14.8
tonsil:25.7
CLEC4MC-type lectin domain family 4, member M
Group enriched7liver:34.7
lymph node:20.6
placenta:12.4
CNR2Cannabinoid receptor 2 (macrophage)
Group enriched7appendix:3.2
lymph node:8.8
spleen:8.1
tonsil:7.2
CXCL13Chemokine (C-X-C motif) ligand 13
Renal cancer: 1.16e-10
Ovarian cancer: 5.41e-4
Endometrial cancer: 5.52e-4
Colorectal cancer: 9.12e-4
Group enriched7appendix:170.3
lymph node:606.7
spleen:430.3
tonsil:411.9
FCER2Fc fragment of IgE, low affinity II, receptor for (CD23)
Group enriched7appendix:22.9
lymph node:48.1
spleen:53.7
tonsil:39.4
KRT73Keratin 73, type II
Group enriched7lymph node:2.6
skin:12.2
TLR10Toll-like receptor 10
Group enriched7appendix:22.0
lymph node:52.3
spleen:35.2
tonsil:46.8
CCR7Chemokine (C-C motif) receptor 7
MitochondriaHead and neck cancer: 7.61e-7
Cervical cancer: 8.03e-6
Breast cancer: 3.84e-4
Testis cancer: 7.72e-4
Group enriched6appendix:91.9
lymph node:98.3
spleen:39.9
tonsil:80.2
CD79ACD79a molecule, immunoglobulin-associated alpha
Head and neck cancer: 1.18e-5
Renal cancer: 2.15e-5
Breast cancer: 8.45e-5
Group enriched6appendix:275.4
lymph node:522.9
spleen:324.4
tonsil:440.3
CETPCholesteryl ester transfer protein, plasma
Group enriched6adipose tissue:36.8
liver:21.6
lymph node:47.1
placenta:50.0
spleen:79.2
CLEC4GC-type lectin domain family 4, member G
Group enriched6adipose tissue:18.5
liver:27.6
lymph node:17.0
DNMT3LDNA (cytosine-5-)-methyltransferase 3-likeN/A
Nuclear specklesGroup enriched6kidney:7.4
liver:10.8
lymph node:2.3
POU2F2POU class 2 homeobox 2
NucleoplasmRenal cancer: 7.57e-11
Group enriched6appendix:37.8
lymph node:62.5
spleen:37.2
tonsil:45.5
RGS13Regulator of G-protein signaling 13
Group enriched6appendix:14.8
lymph node:69.2
tonsil:38.3
SP140SP140 nuclear body protein
Nucleoli fibrillar center
Mitochondria		Group enriched6appendix:34.0
lymph node:65.2
spleen:38.9
tonsil:52.9
STAP1Signal transducing adaptor family member 1
Nucleoplasm
Vesicles		Group enriched6appendix:24.7
kidney:13.1
lymph node:60.3
spleen:27.0
tonsil:58.9
TIMD4T-cell immunoglobulin and mucin domain containing 4
Plasma membrane
Cytosol		Renal cancer: 3.37e-4
Group enriched6lymph node:64.4
testis:161.6
TMEM156Transmembrane protein 156
Breast cancer: 4.09e-4
Group enriched6appendix:12.2
lymph node:28.1
spleen:15.4
tonsil:25.3
urinary bladder:5.9
AC018755.18
Group enriched5appendix:7.3
bone marrow:14.2
lymph node:3.6
spleen:5.0
ANKRD55Ankyrin repeat domain 55
Group enriched5lymph node:4.2
testis:17.2
BANK1B-cell scaffold protein with ankyrin repeats 1
Nucleoplasm
Plasma membrane
Cytosol		Group enriched5appendix:47.6
lymph node:97.9
spleen:78.5
thyroid gland:21.5
tonsil:90.9
CCL19Chemokine (C-C motif) ligand 19
Renal cancer: 8.63e-7
Cervical cancer: 9.91e-6
Breast cancer: 2.88e-5
Group enriched5adipose tissue:171.7
appendix:807.5
lymph node:715.5
tonsil:578.1
CD79BCD79b molecule, immunoglobulin-associated beta
Nucleoplasm
Plasma membrane
Cytosol		Head and neck cancer: 2.35e-4
Group enriched5appendix:94.7
lymph node:315.6
spleen:160.3
tonsil:196.1
FCRL4Fc receptor-like 4
Group enriched5appendix:3.7
lymph node:4.5
tonsil:10.1
HLA-DOBMajor histocompatibility complex, class II, DO beta
Renal cancer: 3.15e-5
Ovarian cancer: 4.17e-5
Breast cancer: 4.29e-4
Group enriched5lymph node:19.9
spleen:18.8
tonsil:31.8
urinary bladder:8.6
HTR3A5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
Endometrial cancer: 1.26e-4
Cervical cancer: 6.26e-4
Group enriched5appendix:2.9
lymph node:7.9
tonsil:7.4
IL24Interleukin 24
Breast cancer: 5.09e-4
Group enriched5appendix:17.9
lymph node:37.6
spleen:30.0
tonsil:28.5
LIMD2LIM domain containing 2
VesiclesRenal cancer: 5.36e-11
Group enriched5appendix:145.1
bone marrow:71.3
lymph node:259.7
spleen:195.3
tonsil:145.7
SIT1Signaling threshold regulating transmembrane adaptor 1
Endometrial cancer: 1.94e-6
Renal cancer: 1.75e-5
Head and neck cancer: 1.14e-4
Cervical cancer: 6.56e-4
Melanoma: 8.17e-4
Group enriched5appendix:25.6
lymph node:56.9
spleen:22.3
tonsil:30.9
AC019206.1
Tissue enhancedlymph node:9.4
AC123512.1
Tissue enhancedlymph node:9.8
AC123512.3Uncharacterized protein C12orf79
Tissue enhancedlymph node:3.8

Page of 6 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.